NCT04430725View on ClinicalTrials.gov

Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study

Active, not recruitingOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

August 7, 2019

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Lung Non-Small Cell CarcinomaMetastatic Colorectal CarcinomaMetastatic SarcomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVB Lung Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8
Interventions
PROCEDURE

Computed Tomography with Contrast

Undergo contrast-enhanced CT

PROCEDURE

Microwave Ablation

Undergo microwave ablation

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Wedge Excision

Undergo wedge resection

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04430725 - Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study | Biotech Hunter | Biotech Hunter